Nomograms for predicting recurrence of <scp>HER2</scp>‐positive breast cancer with different <scp>HR</scp> status based on ultrasound and clinicopathological characteristics
Ultrasound performance of HER2+ breast cancers with different HR status was significantly different. Nomograms integrating ultrasound and clinicopathological characteristics exhibited favorable performance and have the potential to serve as a reliable method for predicting recurrence in heterogeneous breast cancer.
Authors
- Lei Zhang (ORCID: https://orcid.org/0000-0003-4143-668X)
- Hanqing Kong
- Junjia Wang (ORCID: https://orcid.org/0000-0003-0872-4794)
- Nana Hu
- Qingxiang Li (ORCID: https://orcid.org/0000-0002-1424-4108)
- Xu Dong Zhang (ORCID: https://orcid.org/0000-0001-9457-8003)
- Zi‐Hao Qin (ORCID: https://orcid.org/0000-0003-0286-6847)
- Xiaoxue Liu (ORCID: https://orcid.org/0000-0002-1122-5745)
- Jiawei Tian (ORCID: https://orcid.org/0000-0001-6674-8714)
- Hao Cui (ORCID: https://orcid.org/0000-0002-1286-1196)
- Xinran Fang
Institutions
- Harbin Medical University (CN)
- Second Affiliated Hospital of Harbin Medical University (CN)
- First Affiliated Hospital of Harbin Medical University (CN)
Publication Details
- Journal
- Cancer Medicine
- Published
- 2024-09-01
- DOI
- https://doi.org/10.1002/cam4.70146
- Citations
- 5
- Primary Topic
- Breast Cancer Treatment Studies
- Type
- article
- Field-Weighted Citation Impact
- 1.43
Funders
- National Natural Science Foundation of China